<DOC>
	<DOCNO>NCT02869815</DOCNO>
	<brief_summary>The value sentinel lymph node biopsy ( SLNB ) patient underwent neoadjuvant chemotherapy controversial . Lower detection rate high false negative rate main problem . The purpose study determine detection rate false negative rate SLNB indocyanine green ( ICG ) addition blue dye ( methylene blue ) neoadjuvant chemotherapy patient large locally advanced breast cancer . This single arm clinical trial .</brief_summary>
	<brief_title>ICG Blue Dye Guided Sentinel Lymph Node Biopsy Patients Underwent Neoadjuvant Therapy</brief_title>
	<detailed_description>Patients indicate neoadjuvant therapy would recruit study . During surgery , SLNB use dual tracing method would apply axillary clearance . After surgery , histological result SLN non-SLN would analyse .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Methylene Blue</mesh_term>
	<criteria>Patients indicate neoadjuvant therapy Have complete evaluation axillary status Planned axillary clearance neoadjuvant therapy Sensitive Iodine Inflammatory disease Patient 's refusal join trial</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Methylene blue</keyword>
	<keyword>Indocyanine green</keyword>
	<keyword>Neoadjuvant Therapy</keyword>
	<keyword>Sentinel Lymph Node Biopsy</keyword>
	<keyword>Breast Neoplasms</keyword>
</DOC>